Director of Investor Relations at Optasia as a financial technology platform. Leading investment community engagement ensuring transparent communication with investors, analysts, and stakeholders.
Responsibilities
Build and maintain strong relationships with investors, analysts, and financial stakeholders.
Translate financial and ESG performance into clear, investor-friendly messaging.
Serve as the primary point of contact for investor queries, ensuring timely, accurate, and compliant responses.
Monitor investor sentiment, analyst coverage, and ESG ratings to provide insights to leadership.
Lead preparation of Optasia’s sustainability reporting (annual ESG report, KPIs, and frameworks such as GRI/SASB/TCFD).
Ensure ESG disclosures align with investor expectations and international best practices.
Work with Marketing & Strategy to embed ESG into Optasia’s brand and purpose-driven positioning.
Engage with ESG-focused investors, funds, and rating agencies to strengthen Optasia’s sustainability profile.
Oversee quarterly, half-year, and annual investor communication packages.
Ensure accuracy, compliance, and consistency across all financial and ESG disclosures.
Partner with Finance to align investor messaging with financial reporting and ESG metrics.
Plan and execute investor briefings, non-deal roadshows, and participation in financial conferences.
Lead organization of investor days and quarterly results presentations.
Support CEO, CFO, and CSO in all investor-facing events and speaking opportunities.
Maintain investor and ESG stakeholder databases, engagement logs, and feedback records.
Provide shareholder and ESG insights to management and the Board to inform strategy and governance decisions.
Manage communications with institutional investors and other shareholder group
Requirements
10+ years’ experience in investor relations, capital markets, equity research, or corporate finance.
Strong financial and analytical skills with ability to simplify complex data and ESG metrics.
Familiarity with ESG frameworks (GRI, SASB, TCFD, UN SDGs) and investor disclosure best practices.
Established network with institutional investors and analysts is an advantage.
Excellent writing, presentation, and communication skills.
Associate Director leading innovation initiatives for LGBTQ+ health at Penn. Overseeing project execution and sustainability strategies to improve health outcomes.
Associate Director of Biostatistics leading clinical biostatistics globally in drug development. Collaborating with cross - functional teams and mentoring statisticians for innovative statistical methods.
Associate Director leading medical information strategy for Regeneron’s therapeutic areas. Managing tactical execution of medical affairs plans and providing scientific support for healthcare professionals.
Executive Director leading oncology asset development and drug strategy at a healthcare company. Responsible for strategies across all phases from discovery to reimbursement.
Associate Director driving Lean Transformation and Continuous Improvement in a global healthcare leader. Engaging with business leaders to enhance operational performance across multiple sites.
Associate Director for Contracts providing senior - level leadership in negotiating complex research agreements. Overseeing compliance and operational procedures in grants and contracts within Rice University.
Director overseeing eDiscovery delivery operations at Kroll in India. Leading a high - performing team for complex investigations and litigation support.
Regional Director of Outreach leading the outreach team in the Southeast US, focusing on behavioral health relationships and ensuring strategic goals are met. Responsibilities include team development, outreach strategy, and stakeholder engagement.
Director managing strategic advocacy initiatives to ensure patient access for Johnson & Johnson Innovative Medicine. Developing partnerships and executing plans to shape healthcare policies affecting access.
Regional Director managing Cardiovascular sales and clinical teams within D.C./Virginia. Aiming to improve patient outcomes while achieving sales growth in medical device sector.